« Return to News | CROs/Service Providers

Survey: ICON Medical Imaging rated top provider

Thursday, November 17, 2011 01:14 PM

Dublin-based ICON has reported that its Medical Imaging division was rated as the top provider of imaging services according to an industry survey conducted by Blue Pyramid Consulting, an affiliate of the Avoca Group.

According to the survey results, ICON Medical Imaging was ranked 1st as the provider most likely to be chosen for future projects. ICON Medical Imaging also received the highest overall ranking for service provider attributes, including operational excellence, technology, scientific/therapeutic expertise, customer responsiveness, value, reputation, financial stability and ability to bundle services. For therapeutic expertise, ICON was voted the leading imaging provider for oncology, cardiovascular and device studies.

Ted Gastineau, president, ICON Medical Imaging, said “We are delighted with the Blue Pyramid survey results and they reflect the dedication of our team in bringing together innovative technology and a customer service model that ensures quality results on every study. Our technology, medical and regulatory expertise have helped clients to accelerate decision-making for many years and we will continue to help them realise the benefits of imaging services across all therapeutic areas and phases of development.”

The Blue Pyramid Consulting survey was developed to gain an insight into the drivers for selecting medical imaging core laboratory providers for clinical research. The online survey was conducted in the first quarter of 2011 and responses were collected from 133 professionals from pharmaceutical, biotech, medical device, not for profit and academic institutions.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.